TWM
COLL icon

Thrive Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Thrive Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,326
Closed -$941K – 240
2025
Q4 		$941K Sell
20,326
-3,650
-15% -$153K 0.14% 86
2025
Q3 		$839K Hold
23,976
– – 0.13% 91
2025
Q2 		$709K Hold
23,976
– – 0.11% 99
2025
Q1 		$716K Hold
23,976
– – 0.14% 90
2024
Q4 		$687K Sell
23,976
-88
-0.4% -$2.91K 0.12% 91
2024
Q3 		$930K Buy
24,064
+88
+0.4% +$3.14K 0.17% 76
2024
Q2 		$772K Buy
+23,976
New +$831K 0.15% 82

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Thrive Wealth Management's COLL Position: Q1 2026 in Review

Thrive Wealth Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 20,326 shares — an estimated $941K sold.

Thrive Wealth Management first reported a position in COLL in Q2 2024 and held it in 7 quarters. The position peaked at $941K in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Thrive Wealth Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Thrive Wealth Management sold 20,326 Collegium Pharmaceutical shares in Q1 2026, an estimated $941K.
  • Thrive Wealth Management first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 7 quarters.
  • Thrive Wealth Management's Collegium Pharmaceutical position peaked at $941K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Thrive Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.